Tafamidis treatment for transthyretin amyloid cardiomyopathy: results from an open-label, early-access, long-term study extension in an all-comers population

María G. Crespo‐Leiro, Brian Drachman, Thibaud Damy et al.|European Heart Journal|2024

Cited by 0